In Latest US OTC Switch, Ivermectin 0.5% Lice Treatment Becomes Fully Nonprescription

Arbor Pharmaceuticals’ Sklice was approved for OTC sales after being the only Rx ivermectin 0.5% approved for lice treatment available in the US.
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Rx-to-OTC Switch

More from Health